Sign in
4

Changes in Ownership

ORAMED PHARMACEUTICALS INC. Filed Acc 0001213900-17-011195

Director acquired 16,892 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Slager David Mark Director 2017-10-31 Option exercise +16,892 $3.77 $63,609 1,316,328 I
Derivatives
Slager David Mark Director 2017-10-31 Option exercise · Warrant (right to buy) −16,892 $1.18 $19,926 0 I
Loading xslF345X03/f4103117slager_oramedpharm.xml…